1. Home
  2. AZTR

AZTR

Azitra Inc

Logo Azitra Inc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

Founded: 2014 Country:
United States
United States
Employees: N/A City: BRANFORD
Market Cap: 5.4M IPO Year: 2023
Target Price: N/A AVG Volume (30 days): 605.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.83 EPS Growth: N/A
52 Week Low/High: $0.16 - $5.18 Next Earning Date: 05-06-2024
Revenue: $686,000 Revenue Growth: 141.55%
Revenue Growth (this year): 123.03% Revenue Growth (next year): N/A

Share on Social Networks: